5383201
9780230008663
Challenging Pharmaceutical Regulationprovides the first comparative assessment of the performance of the FDA and the supranational EU since 1995 with respect to therapeutic advance, innovation and public health. In particular, it is the first assessment of the impact of various kinds of accelerated regulatory review in the US and EU since the early 1990s on these regulatory institutions, and on pharmaceutical regulation and innovation in the two super-states more generally.John Abraham is the author of 'Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science (Health, Technology and Society)', published 2013 under ISBN 9780230008663 and ISBN 0230008666.
[read more]